The immunodepressive activity of murine leuke~ia viruses (MuLV) is weII documented. However, d~sp~te intensive investigations in many laboratories, the sIgmficance of such immunodepression to tumorigenesis per se and the mechanisms involved remain unclear (1) . Perhaps the most important factor contributing to the uncertainties concerning the significance of immunodepression to leukemogenici ty in M uLV infections has been the strict temporal correlation between development of a neoplastic process and immunologic impairment caused by viruses that induce both early (Friend and Rauscher) and late (Gross and Moloney) leukemias. This relationship has made it difficult to distinguish ceIIular and subceIIular events responsible directly for immunodepression from those that are a consequence of the neoplastic process per se and not a causal event. For this reason, the recent separation from the Friend leukemia virus (FLV) complex of the lymphatic leukemia virus (es) (LLV), which induces lymphomas only after a latent period of several months but depresses immunologic function early after infection~2-4), provided a valuable model system for a rational approach to assessment of the function of immunosuppression by M uLV in the neoplastic process.
Studies based on infection of mice with individual components of murine oncornavirus complexes rather than with the intact virus complex permit dissection of some events associated with immunodepression and leukemogenesis. However, the presence in FLV complexes of immunodepressive LLV and the failure to separate FLV completely from LLV, as well as other considerations (5) (6) (7) , have suggested that these virus components are important "helpers" not only for leukemogenesis but also for immunosuppression, which may be a necessary prerequisite for progression of the neoplastic process after virus infection. For example, previous studies have characterized the immunologic impairment induced by Rowson-Parr virus (RPV), an LLV that has been successfully separated from the FLV complex (2) 7-12). 6 Mice infected with RPV show a rapid and marked diminution of immunoresponsiveness to an antigen such as sheep red blood cells (SRBC). Thus immunosuppression attributed to FLV may be due at least partly (especially, early in the course of the disease) to the RPV component. Lymphoma and other symptoms of leukemia do not develop for about 4-6 weeks after infection of mice with isolated RPV. Nevertheless, a prompt and consistent viremia develops in these mice and persists for an extended time.
Recent studies in this laboratory showed that splenocytes from mice infected with the complete FLV complex can suppress immune competence of "target" spleen cells from normal mice when the ceIIs are cultured in vitro with a test antigen such as SRBC. In the present study, we found that RPV-infected splenocytes free of detectable FLV were immunologicaIIy deficient in vitro and produced markedly fewer antibodies to SRBC than did normal spleen ceIIs. Splenocytes from RPV-infected donor mice also markedly suppressed responsiveness of normal splenocytes to SRBC. The immunodepression induced by RPV-infected cells could be abolished by various means, including nonspecific stimulation with bacterial endotoxins and addition of normal peritoneal exudate (PE) macrophages. These reconstitution experiments with PE ceIIs, in particular, provide information concerning the possible mechanism of the tumor virus-induced immunosuppression.
MATERIALS AND METHODS
Animals.-Young adult male BALB/c mice were obtained from Cumberland View Farms, Clinton, Tennessee. They each weighed approximately 20 g at the time spleen cells were obtained for tissue culture.
Tumor virus.-The preparation of RPV consisted of a single batch of a clarified 10C,1o spleen cell extract obtained from adult BALB/c mice 8 days after infection with the virus; the stock preparation had a titer of 10 4 mean infectious dose (s) (ID50) 10.1 ml when inoculated ip into adult BALBjc mice. The RPV preparation was 7 N-2-Hydroxyethylpiperazine-N'-2-ethanesulfonic acid.
TEXT-FIGURE I.-Effect of duration of RPV infection of donor
BALBjc mice on ability of splenocytes to mount primary immune response in vitro to SRBC. Each point represents average PFC response for several cultures for day indicated after infection of donors with virus.
RESULTS

Response of Splenocytes From RPF·lnfected Mice to SRBC In Vitro
Prior studies showed that infection of BALBIc mice with RPV resulted in a prompt diminution of the immune responsiveness of the animals to SRBC, as evinced by markedly depressed formation of PFC against SRBC. Although no significant splenomegaly or other symptoms of leukemia become evident for at least 4-6 weeks, a 90% or greater suppression in the number of PFC was evident within a few days after infection. Spleen cells from RPV-infected mice continued to show marked hyporesponsiveness to SRBC when immunized in vitro (text- fig. 1 ). The mean hemolytic plaque response (±SD) of splenocytes from normal mice in the; presence of SRBC, in over 20 experiments, was l,006± 130 PFCjl06 viable cells recovered. RPV rapidly reduced responsiveness of the spleen cells to the SRBC in the same culture 2 ml FCS, the cells were washed twice and resuspended in culture medium.
Treatment of cells with antiserum.-Anti-theta serum was prepared by repeated inoculation of AKR mice ip with 10 7 thymocytes from C3H mice and absorption of the resulting serum specimens with agarose and erythrocytes plus bone marrow from C3H and BALBIc mice. Ten million PE cells were then suspended in this antiserum, diluted 1:5 in medium, and incubated for 30 minutes at 37°C with occasional shaking. The cells were washed twice with medium by low-speed centrifugation at 4°C and resuspended in a I: 10 dilution of sterile serum from guinea pigs (as a source of complement, absorbed wi th agarose and BALBIc erythrocytes) . After 30 minutes' incubation at 37°C, the cells were again washed twice and resuspended in culture medium. Control cells were treated with normal AKR serum and complement. The spleen cells treated with anti-theta serum lost their ability to form rosettes with untreated SRBC and respond to phytohemagglutinin in vitro, as shown by markedly reduced tritiated thymidine uptake assays.
",e.-J- free of detectable lactate dehydrogenase virus or lymphocytic choriomeningitis virus. FLV was prepared like RPV from spleens of BALB/c mice and had a titer of 10 3 • 75 ID5010.1 ml. This preparation was also free of detectable contaminating virus. The passage histories of the virus strains were described in (8) .
Infection of mice.-Young adult BALB/c mice were inoculated ip with 0.2 ml virus preparation.
Antigen.-SRBC in Alsever's solution were purchased from Baltimore Biological Laboratories, Baltimore, Maryland. They were washed several times and suspended in culture medium to the concentrations indicated.
Cell suspensions.-Spleen, thymus, and bone marrow were obtained from several mice, and single cell suspensions were prepared in culture medium, as described in (8~9). Adherent spleen cell populations were prepared according to the method of Mosier (13); cells were detached from glass culture vessels with the aid of a rubber policeman. Approximately 75-80% of the adherent cells appeared by histologic criteria to be macrophages; over 90% phagocytized 3 or more SRBC within 30 minutes when incubated at 37°C. T cells educated to SRBC consisted of spleen cells from BALBIc mice irradiated 7 days earlier (700 R whole-body X-irradiation) and inoculated iv with 5x 10 7 syngeneic thymus cells from normal mice and 5 X 10 8 SRBC in 1.0 ml medium (14) . PE cells were harvested from BALBIc mice inoculated ip 5 days earlier with 1.0 ml 2% proteose peptone (#2; Difco Laboratories, Detroit, Mich.) in saline; the peritoneal cavity was washed with 5.0 ml medium (15) . By both morphologic characteristics and phagocytic activity, over 85% of the cells appeared to be macrophages. All cell preparations were washed once by lowspeed centrifugation at 4°C with sterile medium, and viabili ty of the nucleated cells was determined by trypan blue dye exclusion. The cells were then resuspended in culture medium at the concentration required.
Tissue culture.-A modified Marbrook culture system was used (16~17). Spleen cells (5X 10 6 ) suspended in 0.5 ml medium, either alone or with SRBC (2 X 106), were placed in the central culture chamber separated by a dialysis membrane from the outer chamber containing a reservoir of 11 ml sterile medium. The medium consisted of Eagle's minimum essential medium with Hanks' base (MEM), supplemented with nonessential amino acids, sodium pyruvate, glutamine (Gibco, Grand Island, N.Y.), and 10% fetal calf serum (FCS). The medium was buffered with bicarbonate and Mycostatin (50 U Iml) , streptomycin (50 p.g/ml), and penicillin (50 U Iml added. In some experiments, 2-mercaptoethanol (2-Me) or lipopolysaccaride B (LPS) from Escherichia coli 0127: B8 (Difco Laboratories) was added to the cultures. After 5 days' incubation in an atmosphere of 10% COz, 7% Oz, and 83% N,z at 37°C, the cells in the central chamber were tested for viability and for direct plaqueforming cell(s) (PFC) by the localized hemolysis-in-gel assay with SRBC as test antigen (18) . Duplicate cultures were prepared for each assay. The results were expressed as the mean number of PFC/I0 6 viable nucleated cells recovered per culture at the end of the incubation period.
Spleen cell trypsinization.-Spleen cells were washed in medium, resuspended to a concentration of 10 7 cells/ml in HEPES7-buffered MEM containing I mg trypsin/ml (Fisher Scientific Co., Philadelphia, Pa.) , and incubated at 37°C for 10-20 minutes. After addition of spleen cells from normal and infected (5 days) mice were determined by testing for PFC at various times after culture initiation. At all time intervals, the number of PFC in cultures from infected mice was much lower than in cultures containing splenocytes from noninfected mice. The maximum differences occurred on the day of peak response, i.e., the fifth day after culture initiation. Text-figure 3 presents the results of several experiments in which the amount of antigen added to cultures was varied. An increasing number of SRBC above the standard dose of 2 X I ()6 per culture vessel did not stimulate and actually reduced the PFC responsiveness of splenocytes from normal donor mice. In contrast, spleen cells from donors infected with RPV for 5 days produced progressively higher numbers of PFC when incubated with larger doses of antigen; in the presence of 2 X 10 8 SRBC, these spleen cells formed ten times more PFC than those induced by the standard antigen dose.
Respon,se of Splenocytes From RPF·infected Mice to SRBC In tion With RPV·lnfectedSpteen Cells
Since the hyporesponsive spleen cell suspensions from RPV-infected mice, at least early in the course of infection, undoubtedly contained many normal, noninfected lymphoid cells besides cells actively replicating virus, it was of interest to determine whether infected splenocytes could affect the immunoresponsiveness of normal spleen cells. Varying numbers of spleen cells from RPVinfected mice were mixed with 5 X 10 6 spleen cells from noninfected donor mice at the initiation of culture incubation. Splenocytes from RPV-infected mice markedly diminished the PFC responsiveness of normal splenocytes regardless of the duration of infection of the donor mice or the extent of low reactivity of these donor mice in vivo (table I) . For example, the response of spleen 6 4 5 DAYS OF CULTURE 3 system. Three days after infection, the mean PFC response was 5%, of that exhibited by normal splenocytes. Maximum depression .of reactivity was evident when the interval between infection and spleen cell cultivation was 4-8 days. At that time, no culture produced more than 25'% of the PFC present in control cultures. Most responses were 10% or less that of controls. After the second week of RPV infection, the reduction of responsiveness was still evident, but its extent varied greatly; some cultures produced very few PFC and others had normal or near-normal numbers. The hyporesponsive PFC formation in vitro occurred in the absence of marked splenomegaly of the infected donor mice. For example, 5 days after RPV injection the spleens averaged only 137 ± 27 mg versus 119 ± 19 mg for normal spleens. Definite splenomegaly became evident during the second and third weeks of infection; however, the spleen weight increase was still moderate. The largest spleen size observed at that time in infected mice was 276 mg. Also, infection did not significantly influence the survival of cells in culture. For example, in the II assays on spleen cells obtained 5 days after infection of donor mice, the mean number of cells recovered per culture was l.13 ± 0.34 X 10 6 in the case of infected mice and l.37 ± 0.36 X 10 6 in the case of normal mice. cells from animals infected with RPV for 36 days was about 50% that of the noninfected animals. Spleen cells from these infected mice were as effective in inhibiting normal splenocyte responsiveness to SRBC as were spleen cells from mice infected 5 days; these produced only 3% of the PFC evident in normal control mice used for comparison. The induction of hyporeactivity in the spleen cell cultures required as few as 10 3 infected cells. For example, addition of this relatively small number of cells from mice infected either 5, 15, or 36 days to cultures containing 5 X 10 6 normal spleen cells resulted in a 40-60% suppression of the PFC response as compared to the cultures containing no infected cells. Table 2 presents the results of experiments in which cultures of spleen cells derived from normal or infected (5 days) mice were subjected to trypsinization before incubation or were cultured in the presence of 2-Me or E. coli LPS. Treatment with trypsin for 10-20 minutes before culture initiation slightly decreased the number of PFC produced by both normal and infected cells and also reduced cell recovery. Incubation of the spleen cells in the presence of varying concentrations of 2-Me increased cell recovery but did not influence the PFC response of either normal or infected splenocytes. In contrast, incubation of infected spleen cells with LPS, although it did not significantly influence cell recovery, effected a dose-dependent increase in the number of PFC. However, LPS did not affect the PFC response of spleen cells from normal mice. Addition of 10 fJ-g LPS to cultures of spleen cells from RPV-infected mice resulted in a PFC response to SRBC equivalent or greater than that occurring with the same number of spleen cells from normal mice.
Effect of Various Treatments In Vitro on Responsiveness of RPV-Infected Splenocytes
Effect of Lymphoid Cells From Uninfected Mice on Response of RPV-Infected Splenocytes
Although relatively few RPV-infected splenocytes markedly affected immune responsiveness of normal mouse spleen cells, it was of interest to determine in the reverse situation whether graded numbers of different classes of cells from noninfected animals could influence the immunologic unresponsiveness of cells from infected animals. Various numbers of PE cells, as well as thymus, bone marrow, or spleen cells were added to 5 X 10 6 cells from RPV-infected donors. PFC responsiveness was not restored in any culture containing thymus, bone marrow, or spleen cells from noninfected mice, regardless of their numbers (table 3) . In contrast, PE cells markedly enhanced responsiveness of RPV-infected splenocytes (table 4, text- fig. 4 ). No PFC were produced by PE cells cultured alone. In a typical experiment (table 4), maximum restoration of the response of infected splenocytes was achieved by addi tion of 3 X 10 5 PE cells. Furthermore, in some experiments, maximum restoration was achieved with as few as IX 105PE cells. Often thePFC response of both normal and infected splenocytes was inhibited as the number of added PE cells was increased. Also, the addition of adherent normal spleen cells could only partially restore the unresponsiveness of the infected spleen cells; adherent spleen cells always resulted in fewer PFC than did equivalent numbers of PE cells added to the cultures.
Prior treatment of PE cells with AKR normal or anti-theta serum and complement did not affect the ability of. the. cells to overcome the. imm:unodepression induced by RPV infection (text- fig. 4 ) . The responsiveness of uninfected splenocytes to SRBC in vitro, however, was not altered by incubation of the cells wi th the same number of PE cells, whether treated with antiserum or untreated. In other experiments (not presented here), RPV-infected mice demonstrated that depression was not due to prolongation of the lag phase or to a delay in the peak day of antibody formation. Thus depressed PFC formation in vitro by splenocytes of RPV-infected mice appeared to be a direct and early consequence of virus infection and not of secondary events associated with neoplastic proliferation of lymphoid cells.
-Effect of various treatments on primary response in vitro of uninfected and RPV-infected splenocytes
the low reactivity of spleen cells from chronically infected mice (20to 3D-day infection) was also readily susceptible to restoration by PE cells in vitro.
Effect of PE Cells on Immunoimpairment Induced by RPV· Infected Splenocytes in Noninfected Cells
Uninfected splenocytes were mixed with various numbers of spleen cells taken from mice either 5 or 36 days after infection, and the mixtures were cultured either with or without further addition of PE cells. The addition of PE cells not only failed to prevent the depression of PFC responsiveness in cultures c0111aining normal cells incubated with RPV-infected spleen cells, but often increased the level of that depression (table 5) .
DISCUSSION
Previous studies indicated that immunologic impairment occurs in BALBjc mice after infection with RPV (2, (7) (8) (9) (10) (11) (12) .f3 In the present study, the antibody response of splenocytes from mice infected with this virus and stimulated in Marbrook chambers with SRBC was depressed when the cells were derived from animals infected 3 or more days earlier. This relationship between the extent of immunodepression and the time of infection is similar to that observed in the intact animal (2, 9) ; an early phase of profound and constant suppression is followed by a long-lasting period during which the splenocytes show variable, though generally reduced, immunoresponsiveness. In this respect the depression induced by RPV differs from that produced by FLV, since the latter virus, both in vivo (1, 19, 20) and in vitro (21), induces a progressively more severe immunosuppression as the period of infection increases.
In the attempts to analyze the cellular basis of the immunodepression induced by RPV, attention was focused on the early phase of more intense immunologic hyporeactivity. That this hyporesponsiveness is not attributable to dilution of immunocompetent spleen cells by other cells is evidenced by the lack of correlation between extent of immunodepression and degree of splenomegaly in this study and in previous work (10) . Furthermore, unlike the situation in FLV-infected mice, neoplastic changes begin to appear in the spleens of RPV-infected mice only after 4-6 weeks or longer (2, 3, 22) . Analysis of the kinetics of in vitro PFC responses in Another important analogy between in vitro and in vivo PFC responses of RPV-infected spleens to SRBC is that the hyporesponsiveness could be markedly reversed by increases in the dose of antigen used for challenge (9) . In vitro, however, this phenomenon was more striking because normal cells failed to give higher responses when cultured in the presence of larger doses of SRBC. The increased responses by spleen cells of RPV-infected mice immunized in vitro with the higher SRBC dose clearly indicate that infected spleen cells contain competent B cell-dependent PFC precursor cells in sufficient numbers to mount a normal response when properly stimulated. This conclusion was strengthened by the finding that spleen cells from RPV-infected mice, when the cells were cultured in the presence of standard doses of SRBC, produced normal numbers of PFC if LPS was added to the system. Since LPS is known to substitute for certain accessory cell types [such as adherent cells and thymus-derived lymphocytes (23)] otherwise necessary for the antibody response of spleen cells to SRBC in vitro, this finding prompted experiments in which various cell types from normal donor mice were added to RPV-infected splenocytes and the mixtures assayed for antibody production in vitro.
Of all the lymphoid cell types examined for restorative effects, only PE cells caused a substantial reconstitution of the immune response to SRBC. This effect was dose dependent; as few as 3 X 10 4 PE cells produced a consistent restoration of the immune response of 5 X 10 6 spleen cells, and complete recovery was obtained with 1-3 X 10 5 PE cells. At these dosages, PE cells did not significantly modify. the responses of normal splenocytes, which excluded the possibility that PE cells had nonspecifically stimulated all antibody responses. Furthermore, PE cells cultured with SRBC alone did not induce PFC. In keeping with previous results showing that large numbers of macrophages can inhibit immune responses (15, (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) , occasionally 3 X 10 5 PE cells and consistently larger numbers of PE cells inhibited the PFC response of both normal and RPV-infected spleen cells.
The restoring activity of PE cells was confirmed in experiments with splenocytes from· mice chronically infected with RPV; it was present also in the PE cells of mice infected 5 days earlier (unpublished results). Since PE cells consisted of more than 85% macrophages, and since they maintained their restorative activity after prior depletion of T cells by treatment with anti-theta serum and complement, the major cell type responsible for the restorative effect in the PE cell population seemed to be the macrophage. Accordingly, similar addition of normal spleen, bone marrow, or thymus cells had no effect or produced only moderate enhancement of PFC production; this could be explained on the basis of their content of macrophages. T cells educated to SRBC, a cell type which is an effective "helper" for B cells (35, 36) , did not show any restorative effect. Surprisingly, however, adherent spleen cells exerted a lower restoration than PE cells. The reason for this apparent discrepancy is not clear. Peritoneal macrophages and adherent spleen cells have generally been found equivalent as helper cells for macrophage-depleted, nonadherent, spleen cell populations (34, 37, 38) . However, different functional activities have been noted for macrophages derived from different tissue source~.
The cellular events underlying the present findings are undoubtedly enormously complex, and several different mechanisms can be proposed to account for them. However, two interpretations appear most plausible. The first and most obvious one is that the immunologic defect of RPV-infected spleen cell populations resides in the macrophage. Macrophages are considered essential for an optimal PFC response in vitro by spleen cells to multideterminant complex antigens such as SRBC. These cells have at least two distinct functions: They promote the survival of lymphocytes and present andfor process the antigen (31, 34, (37) (38) (39) (40) (41) (42) . Since the number of viable cells recovered from cultures of RPV-infected splenocytes was not significantly lower than that from cultures of normal cells and since the PFC response of infected cells was not potentiated by addition of 2-Me [which is known to replace the viability-promoting function of macrophages (34, 37, 38, 43) and which, accordingly, in the present study also augmented cell recovery], it appears that the macrophage function impaired by RPV infection is the ability to "present" antigen properly to lymphocytes. This impairment of a vital function of macrophages could be due to replication of RPV in these cells or to "blockade" of the cells in their attempt to clear the viremia sustained by RPV (10) . Although macrophages have been reported to support FLV replication (44), little or nothing is known concerning the target cell for RPV replication. However, morphologic alterations of spleen macrophages have been described following RPV infection (22) .
It is also possible that the macrophages in RPV-infected mice are involved in "antigenic competition." Recent theories of antigenic competition (45-47) postulate that T-cell-produced molecules "compete" with each other for sites on the macrophage surface, and in an in vitro model the addition of PE cells~nabled splenocyte responses of the same magnitude as those generated by normal splenocytes not derived from immunodeficient (antigenic competition) splenocyte donors (47). However, the in vitro models of antigenic competition described Downloaded from https://academic.oup.com/jnci/article-abstract/55/6/1425/886537 by guest on 15 February 2020 so far (47-49) differ markedly from the phenomena of RPV-induced immunodepression; among the differences are that immunologic depression due to antigenic competition is relatively independent of the antigen dose (47) 48) and that the immunologic impairment can be reversed by trypsinization (47).
The second possible interpretation of cellular events underlying the present findings is that in RPV-infected mice the B-cell-dependent precursors of antibody-forming cells, although normal in number, are less susceptible to "triggering" and proliferation and/or differentiation into antibody-forming cells and can be induced to so act only if given an extra stimulus. In the experiments presented here, the extra stimulus could be either a very large dose of antigen, LPS, or PE cells. This hypothesis is in keeping with the studies done on FLV immunodepression, repeatedly indicating the lymphocyte as the site of immunologic suppression (1) 21). However, preliminary results indicate that the depression of antibody response in vitro occurring in the early stages of FLV infection can be also reversed by the addi tion of PE cells. Previous findings showing that RPV-infected spleens contain reduced numbers of cells with immunoglobulin receptors demonstrable by immunofluorescence at 4°C with antiserum to immunoglobulin ,and capable of displaying cap formation when incubated at 37°C,6 though not easily evaluated, suggest a possible alteration of B cells that could be overcome by the aid of an extra stimulus. The present data, though providing a firm basis for further dissection at the cellular level of RPVinduced immunodepression, does not permit a definitive identification of the deficient cell type, if a specific one exists.
Another interesting finding of the present study is that RPV-infected splenocytes can readily inhibit the PFC responses of normal spleen cells in vitro. The ability to confer hyporesponsiveness to normal cells in vitro has been described previously for FLV-infected splenocytes (17) and for spleen cells derived from mice heavily preimmunized with heterologous erythrocytes (49). In the present model, the "transfer" of hyporesponsiveness from RPV-infected to normal cells occurred irrespective of the length of RPV infection or the level of immunodepression in the suppressing cells; this transferred immunosuppression was not reversed by the addition of PE cells. Thus there seems to be a major difference between the mechanism of direct RPV-induced immunosuppression and that responsible for the reduced reactivity of RPV-infected cells from actively infected mice.
It is surprising that the PE cells from normal mice had little restorative effect on PFC response of normal spleen cells cultured with the smaller numbers of infected cells. Unlike the situation with PE cells added directly to suppressd splenoeytes from infected mice, PFC responses did not increase in mixed cultures to which additional PE cells from normal animals were added. In all combinations studied (table 5), there were fewer PFC in cultures containing splenocytes from mixed RPV-infee ted and control mice plus normal PE cells than in cultures without added PE cells. This additional suppression occurred regardless of the number of PE cells added (a 2,OOO-fold range). Thus it seems unlikely that the further suppression by additional numbers of PE cells was due to enhanced "digestion" of the SRBC as may occur when large numbers of PE cells are added to cultures of normal splenocytes only (table 2). The additional macrophages added to the cultures may have "competed" with macrophages from the infected mice for a finite number of normal lymphocytes, since it is not known if infection affects macrophage number per se. It would certainly be valuable to determine whether mixtures of normal and infected splenocytes still showed reduced PFC responses with increased doses of SRBC, as occur with the suppressed spleen cell cultures from infected mice. Such experiments are in progress.
The present results do not permit definitive conclusions regarding the contribution of RPV to the immunodepression exerted by FLV preparations. However, the finding that the early phases of immunosuppression induced by FLV are also susceptible to reversal by cocultivation with PE cells, if confirmed, would support the concept that RPV has an important function. Further studies concerning the interrelationship between PE cells, especially macrophages, and tumor virus-induced immunosuppression are under way. 
